Kirk's Market Thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts

COHR 185.85

+2.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian Sullivan who wrote (1226)	5/13/2014 10:41:03 AM
From: Kirk ©	Read Replies (1) of 26729

Interesting that Agilent is one of the few big companies doing spin offs so management can concentrate on doing what it does best. Too bad the instrument company can't get the HP name back... They should have called it "Bill and Dave's Instruments" but maybe that is too close to "Dave and Buster's".... -g- kirklindstrom.com/Charts/A.html Others are merging... AT&T is in reportedly "advanced talks" to acquire DirecTV ( DTV) in a deal that values the satellite-TV provider at $51B, or over $66B after factoring net debt. AT&T ( T) is offering $100 a share, or a 15% premium to DirecTV's close on Monday. Under the plans that are being discussed, DirecTV CEO Mike White plans to retire after 2015. The company's shares rose 5.9% in after-hours trading. Pfizer intends to raise its cash-and-stock bid for AstraZeneca ( AZN) a second time to "modestly" above the current offer of £50 ($84) a share, Bloomberg reports, adding that the U.S. company will increase the cash portion of its proposal from 32%. The report comes as Pfizer ( PFE) CEO Ian Read testifies today about the deal to a U.K. parliamentary panel. AstraZeneca counterpart Pascal Soriot is also appearing at the hearings.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next